October 24, 2022
Frontier Medicines
Developing novel medicines using chemoproteomics and machine learning to accelerate therapies to drug previously considered “undruggable” targets driving human disease, starting with cancer
Developing novel medicines using chemoproteomics and machine learning to accelerate therapies to drug previously considered “undruggable” targets driving human disease, starting with cancer